Enliven Therapeutics, Inc. (ELVN)
NASDAQ: ELVN · Real-Time Price · USD
58.82
+0.76 (1.31%)
At close: Aug 14, 2026, 4:00 PM EDT
58.94
+0.12 (0.21%)
After-hours: Aug 14, 2026, 7:34 PM EDT
Enliven Therapeutics Employees
Enliven Therapeutics had 67 employees as of June 30, 2026. The number of employees increased by 4 or 6.35% compared to the same quarter last year.
Employees
67
Change
4
Growth
6.35%
Revenue / Employee
n/a
Profits / Employee
-$1,581,000
Market Cap
4.31B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 67 | 4 | 6.35% |
| Mar 31, 2026 | 61 | -4 | -6.15% |
| Dec 31, 2025 | 60 | -2 | -3.23% |
| Sep 30, 2025 | 65 | 8 | 14.04% |
| Jun 30, 2025 | 63 | 11 | 21.15% |
| Mar 31, 2025 | 65 | 15 | 30.00% |
| Dec 31, 2024 | 62 | 16 | 34.78% |
| Sep 30, 2024 | 57 | 13 | 29.55% |
| Jun 30, 2024 | 52 | 15 | 40.54% |
| Mar 31, 2024 | 50 | 21 | 72.41% |
| Dec 31, 2023 | 46 | 17 | 58.62% |
| Sep 30, 2023 | 44 | 20 | 83.33% |
| Jun 30, 2023 | 37 | 13 | 54.17% |
| Mar 31, 2023 | 29 | - | - |
| Sep 30, 2022 | 24 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Legend Biotech | 2,965 |
| Telix Pharmaceuticals | 1,184 |
| Denali Therapeutics | 507 |
| Structure Therapeutics | 233 |
| Relay Therapeutics | 202 |
| Celcuity | 155 |
| Parabilis Medicines | 145 |
| Tango Therapeutics | 137 |
ELVN News
- 8 days ago - Enliven price target raised to $75 from $60 at Baird - TheFly
- 8 days ago - Enliven price target raised to $82 from $80 at Stifel - TheFly
- 8 days ago - Enliven price target lowered to $78 from $80 at Guggenheim - TheFly
- 8 days ago - Enliven price target raised to $80 from $67 at Goldman Sachs - TheFly
- 8 days ago - Enliven price target raised to $68 from $55 at Clear Street - TheFly
- 9 days ago - Enliven Therapeutics Reports Second Quarter Financial Results and Provides a Business Update - PRNewsWire
- 9 days ago - Enliven Therapeutics Quarterly report: Q2 2026 - Filings
- 9 days ago - Enliven Therapeutics Earnings release: Q2 2026 - Filings